Intrexon | Dochód Netto





Dochód Netto Zmiana Data
Agenus USD -25.27M 20.59M 2025-03
Alaunos Therapeutics USD -1.16M 417K 2025-09
Amgen USD 1.33B 1.88B 2025-12
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Incyte USD 299.28M 124.89M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD 16.82M 53.07M 2025-09
MannKind USD 668K 12.49M 2025-06
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.93B 96M 2025-09
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Veracyte USD 19.14M 20.12M 2025-09
Xencor USD -6.03M 24.8M 2025-09


Intrexon Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.